Fusion With Post-Translational Modification Motif TRIZ Cases

Engineered platelets use antibody-guided split toxins to kill circulating tumor cells while limiting systemic side effects.

A monoclonal antibody targets free biotin over biotinylated molecules to reduce assay interference and improve analyte measurement accuracy.

Selective tail-moiety binding captures free biotin without binding biotinylated targets, improving avidin-biotin assay accuracy.

Split-intein feedback controllers use antithetic integral control to keep protein expression constant across disturbances and host conditions.